THE Drug Control Authority (DCA) has agreed to approve the conditional registration of the Covid-19 vaccine AstraZeneca Solution for Injection for use during an emergency.
Health Director-General Dr Noor Hisham Abdullah said the decision over the product supplied through the Covax facility by South Korean manufacturer SK Bioscience Co Limited was made at the 355th DCA meeting today.
Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!
Comments